ciprofloxacin and rifamycins

ciprofloxacin has been researched along with rifamycins in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (14.29)	18.7374
1990's	6 (14.29)	18.2507
2000's	12 (28.57)	29.6817
2010's	17 (40.48)	24.3611
2020's	1 (2.38)	2.80

Authors

Authors	Studies
Hjelm, U; Hoffner, SE; Kaustová, J; Kubín, M	1
Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN	1
Kahana, LM; Spino, M	1
Bollet, C; de Micco, P; Gevaudan, MJ; Gulian, C; Mallet, MN	1
Chen, CH; Heifets, LB; Lindholm-Levy, PJ; Shih, JF	1
Klastersky, J; Van der Auwera, P	1
Hadley, WK; Nassos, PS; Yajko, DM	1
Joly, P; Van der Auwera, P	1
Abeck, D; Alexander, F; Ballard, RC; Johnson, AP; Korting, HC	1
Hjelm, U; Hoffner, SE; Källenius, G	1
Brigidi, P; Campieri, M; Ferrieri, A; Gionchetti, P; Johansson, R; Poggioli, G; Rizzello, F; Rossi, M; Ugolini, F; Venturi, A	1
Adachi, JA; Ashley, D; DiCesare, D; DuPont, HL; Ericsson, CD; Glandt, M; Jiang, ZD; Mathewson, JJ	1
Akaki, T; Kajitani, H; Sato, K; Shishido, S; Tomioka, H	1
Adachi, JA; Ashley, D; DuPont, HL; DuPont, MW; Ericsson, CD; Jiang, ZD; Martinez-Sandoval, F; Mathewson, JJ; Palazzini, E; Riopel, LM	1
De Pità, O; Giani, M; Guerra, EC; Pirrotta, L; Puddu, P; Scala, E	1
Marteau, P; Seksik, P	1
Baggiolini, M; Campieri, M; Gionchetti, P; Helwig, U; Kühbacher, T; Lammers, K; Rizzello, F; Schreiber, S; Uguccioni, M	1
Abdelrazeq, AS; Kelly, SM; Leveson, SH; Lund, JN	1
Battaglia, E; Dughera, L; Emanuelli, G; Navino, M; Serra, AM; Tibaudi, D	1
Campieri, M; Gionchetti, P; Morselli, C; Rizzello, F; Romagnoli, R	1
Keenum, AJ; Stockton, MD	1
Iliopoulos, P; Korovessis, P; Koureas, G; Petsinis, G; Zacharatos, S	1
Bourgeois, AL; Dupont, HL; Ericsson, CD; Haake, R; Halpern, J; Jiang, ZD; Steffen, R; Taylor, DN	1
Andresen, V; Layer, P	1
Arslan, O; Kockar, F; Sinan, S; Yildirim, H	1
Cima, RR; Holubar, SD; Pardi, DS; Sandborn, WJ	1
Chatterjee, S; DuPont, HL; Gurleen, K; Jafri, S; Jiang, ZD; McKenzie, R; Nandy, RK; Ouyang-Latimer, J; Ramamurthy, T; Rodriguez, S; Steffen, R; VanTassel, A	1
Abdiche, G; Batellier, L; Borsali, E; Chaumeil, C; Gleize, D; Goldschmdt, P; Laroche, L; Le Bouter, A; Legrand, P	1
Bauwens, A; Bielaszewska, M; Idelevich, EA; Karch, H; Mellmann, A; Peters, G; Schaumburg, F; Zhang, W	1
Kale-Pradhan, PB; Palmer, JR; Wilhelm, SM; Zhao, JJ	1
Guslandi, M	1
Albesa, I; Angel Villegas, N; Baronetti, J; Becerra, MC; Etcheverría, A; Padola, NL; Paraje, MG	1
Colquhoun, JM; Dunman, PM; Wozniak, RA	1
Holubar, SD; Pardi, DS; Sandborn, WJ; Singh, S; Stroud, AM	1
Lübbert, C	1
Tribble, DR	1
Araujo, P; DuPont, HL; Gracias Garcia, ML; Greinwald, R; Jiang, ZD; Nacak, T; Steffen, R; Stiess, M	1
Connor, P; Riddle, MS; Tribble, DR	1
Connor, BA; Ericsson, CD; Riddle, MS	1
DuPont, HL; Steffen, R	1
Almenoff, JS; Bortey, E; DuPont, HL; Jamindar, MS; Steffen, R	1

Reviews

7 review(s) available for ciprofloxacin and rifamycins

Article	Year
Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan. The American review of respiratory disease, 1989, Volume: 140, Issue:4 Topics: Antitubercular Agents; Ciprofloxacin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifamycins; Taiwan; Tuberculosis, Pulmonary; United States	1989
Management of inflammatory bowel disease: does rifaximin offer any promise? Chemotherapy, 2005, Volume: 51 Suppl 1 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Intestinal Absorption; Intestines; Metronidazole; Rifamycins; Rifaximin	2005
Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea. Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:11 Topics: Administration, Oral; Anti-Infective Agents; Antidiarrheals; Ciprofloxacin; Diarrhea; Humans; Loperamide; Rifamycins; Rifaximin; Travel; Treatment Outcome	2010
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. The Cochrane database of systematic reviews, 2010, Jun-16, Issue:6 Topics: Adult; Ciprofloxacin; Colitis, Ulcerative; Enema; Gastrointestinal Agents; Humans; Metronidazole; Postoperative Complications; Pouchitis; Randomized Controlled Trials as Topic; Remission Induction; Rifamycins; Rifaximin; Suppositories	2010
The role of antimicrobials in Crohn's disease. Expert review of gastroenterology & hepatology, 2013, Volume: 7, Issue:3 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Crohn Disease; Humans; Metronidazole; Remission Induction; Rifamycins; Rifaximin; Secondary Prevention; Treatment Outcome	2013
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. The Cochrane database of systematic reviews, 2015, Nov-23, Issue:11 Topics: Adult; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Enema; Gastrointestinal Agents; Humans; Metronidazole; Postoperative Complications; Pouchitis; Randomized Controlled Trials as Topic; Remission Induction; Rifamycins; Rifaximin; Suppositories	2015
Antimicrobial therapy of acute diarrhoea: a clinical review. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:2 Topics: Acute Disease; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campylobacter Infections; Cholera; Ciprofloxacin; Diarrhea; Dysbiosis; Dysentery, Bacillary; Enterocolitis, Pseudomembranous; Escherichia coli Infections; Fidaxomicin; Gastroenteritis; Humans; Rifamycins; Rifaximin; Salmonella Infections; Shiga-Toxigenic Escherichia coli; Yersinia Infections	2016

Trials

6 trial(s) available for ciprofloxacin and rifamycins

Article	Year
Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:2 Topics: Adult; Anti-Infective Agents; Antidiarrheals; Ciprofloxacin; Diarrhea; Escherichia coli; Escherichia coli Infections; Humans; Rifamycins; Rifaximin; Travel; Treatment Outcome	1999
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Dec-01, Volume: 33, Issue:11 Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Double-Blind Method; Feces; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Rifamycins; Rifaximin	2001
Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension. Minerva gastroenterologica e dietologica, 2004, Volume: 50, Issue:2 Topics: Acute Disease; Adjuvants, Immunologic; Administration, Oral; Aged; Analysis of Variance; Anti-Infective Agents; Bacteria; Bacterial Vaccines; Cell Extracts; Chi-Square Distribution; Ciprofloxacin; Colonoscopy; Diverticulitis; Diverticulitis, Colonic; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Injections, Intravenous; Intestinal Mucosa; Male; Middle Aged; Recurrence; Rifamycins; Rifaximin; Time Factors	2004
A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. The American journal of tropical medicine and hygiene, 2006, Volume: 74, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Diarrhea; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Rifamycins; Rifaximin; Travel; Treatment Outcome	2006
Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria. Journal of travel medicine, 2018, 01-01, Volume: 25, Issue:1 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Drug Resistance, Multiple, Bacterial; Ecuador; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Female; Guatemala; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Rifamycins; Travel; Treatment Outcome	2018
Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy. Journal of travel medicine, 2023, 10-31, Volume: 30, Issue:6 Topics: Ciprofloxacin; Diarrhea; Double-Blind Method; Humans; Rifamycins; Travel	2023

Other Studies

29 other study(ies) available for ciprofloxacin and rifamycins

Article	Year
Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:1 Topics: Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Isoniazid; Nontuberculous Mycobacteria; Rifamycins	1992
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum]. Pathologie-biologie, 1991, Volume: 39, Issue:5 Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Minocycline; Mycobacterium; Quinolones; Rifabutin; Rifamycins	1991
Ciprofloxacin in patients with mycobacterial infections: experience in 15 patients. DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Rifabutin; Rifampin; Rifamycins; Tuberculosis, Pulmonary	1991
[Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi]. Pathologie-biologie, 1989, Volume: 37, Issue:5 Pt 2 Topics: Amikacin; Ciprofloxacin; Clofazimine; Drug Therapy, Combination; Erythromycin; Humans; Mycobacterium; Mycobacterium avium Complex; Rifabutin; Rifamycins	1989
In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis. Drugs under experimental and clinical research, 1986, Volume: 12, Issue:4 Topics: Aminocoumarins; Anti-Bacterial Agents; Ciprofloxacin; Coumarins; Drug Combinations; Microbial Sensitivity Tests; Quinolines; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Staphylococcus epidermidis	1986
Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Ciprofloxacin; Clofazimine; Humans; Mycobacterium avium; Rifabutin; Rifamycins; Tuberculosis	1987
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1987, Volume: 19, Issue:3 Topics: Aminocoumarins; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Coumarins; DNA-Directed RNA Polymerases; Drug Interactions; Glycopeptides; Humans; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Teicoplanin; Topoisomerase II Inhibitors; Vancomycin	1987
In vitro activity of eight antimicrobial agents against non-penicillinase-producing gonococci isolated in Munich. Genitourinary medicine, 1988, Volume: 64, Issue:4 Topics: Anti-Bacterial Agents; Ciprofloxacin; Fleroxacin; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Rifamycins; Tetracycline Resistance	1988
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Rifabutin; Rifampin; Rifamycins	1993
Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:6 Topics: Adult; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Pouchitis; Rifamycins; Rifaximin	1999
Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:2 Topics: 4-Quinolones; Aminopyridines; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Rifamycins	2000
Multiple drug allergy syndrome: severe anaphylactic reaction due to topical rifamycin SV in a patient with hypersensitivity to ciprofloxacin. International journal of dermatology, 2001, Volume: 40, Issue:9 Topics: Anaphylaxis; Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Ciprofloxacin; Drug Hypersensitivity; Humans; Male; Middle Aged; Rifamycins	2001
[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease]. Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:2 Pt 2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Escherichia coli; Freeze Drying; Gastrointestinal Agents; Humans; Mesalamine; Placebos; Probiotics; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Saccharomyces; Time Factors	2001
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. International journal of colorectal disease, 2004, Volume: 19, Issue:2 Topics: Adult; Antineoplastic Agents; Chemokine CCL2; Chemokine CXCL10; Chemokines, CC; Chemokines, CXC; Ciprofloxacin; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Interleukin-8; Male; Pouchitis; Proctocolectomy, Restorative; Rifamycins; Rifaximin	2004
Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2005, Volume: 7, Issue:2 Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pouchitis; Rifamycins; Rifaximin; Statistics, Nonparametric; Treatment Outcome	2005
Rifaximin (Xifaxan) for traveler's diarrhea. American family physician, 2005, Dec-15, Volume: 72, Issue:12 Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Gastrointestinal Agents; Humans; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Travel	2005
Anterior surgery with insertion of titanium mesh cage and posterior instrumented fusion performed sequentially on the same day under one anesthesia for septic spondylitis of thoracolumbar spine: is the use of titanium mesh cages safe? Spine, 2006, Apr-20, Volume: 31, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Internal Fixators; Lumbar Vertebrae; Male; Middle Aged; Prostheses and Implants; Retrospective Studies; Rifamycins; Sepsis; Spinal Fusion; Spondylitis; Surgical Mesh; Thoracic Vertebrae; Titanium; Treatment Outcome	2006
[Bacterially induced traveler's diarrhea. Local antibiosis effective without systemic effects]. MMW Fortschritte der Medizin, 2008, Nov-06, Volume: 150, Issue:45 Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Diagnosis, Differential; Diarrhea; Feces; Fluid Therapy; Gastrointestinal Agents; Humans; Rifamycins; Rifaximin; Time Factors; Travel	2008
Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro. Journal of enzyme inhibition and medicinal chemistry, 2010, Volume: 25, Issue:5 Topics: Ampicillin; Anti-Bacterial Agents; Aryldialkylphosphatase; Ciprofloxacin; Clindamycin; Hep G2 Cells; Hepatocytes; Humans; Kinetics; Osmolar Concentration; Rifamycins	2010
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Enterotoxigenic Escherichia coli; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guatemala; Humans; India; Mexico; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Travel	2011
[Ornithinimicrobium pekingense ocular infection]. Medecine et maladies infectieuses, 2011, Volume: 41, Issue:6 Topics: Actinomycetales; Actinomycetales Infections; Aged; Cataract; Ciprofloxacin; Corneal Edema; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Female; Fusidic Acid; Humans; Keratoplasty, Penetrating; Ointments; Ophthalmic Solutions; Postoperative Complications; Rifamycins; Tobramycin	2011
Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6 Topics: Anti-Bacterial Agents; Azithromycin; Bacteriophages; Chloramphenicol; Ciprofloxacin; Escherichia coli; Meropenem; Minocycline; Rifamycins; Rifaximin; Shiga Toxin 2; Thienamycins; Tigecycline	2012
Role of probiotics in the management of pouchitis. Current pharmaceutical design, 2014, Volume: 20, Issue:28 Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colitis, Ulcerative; Humans; Intestines; Metronidazole; Pouchitis; Probiotics; Proctocolectomy, Restorative; Recurrence; Rifamycins; Rifaximin	2014
Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms. Toxicology in vitro : an international journal published in association with BIBRA, 2015, Volume: 29, Issue:7 Topics: Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Biofilms; Catalase; Cell Survival; Chlorocebus aethiops; Ciprofloxacin; Fosfomycin; Glutathione; Microbial Sensitivity Tests; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Rifamycins; Rifaximin; Shiga Toxin 1; Shiga Toxin 2; Shiga-Toxigenic Escherichia coli; Superoxide Dismutase; Vero Cells; Virulence Factors	2015
Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents. PloS one, 2015, Volume: 10, Issue:11 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Lung; Microbial Sensitivity Tests; Rifampin; Rifamycins; Rifaximin; Tetracycline	2015
Antibiotic Therapy for Acute Watery Diarrhea and Dysentery. Military medicine, 2017, Volume: 182, Issue:S2 Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Developing Countries; Diarrhea; Dysentery; Humans; Levofloxacin; Military Personnel; Rifamycins; Rifaximin	2017
Antibiotics for Travellers' Diarrhoea on Trial-is there a potential role for Rifamycin SV? Journal of travel medicine, 2019, 01-01, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Diarrhea; Humans; Rifamycins; Travel	2019
When should travel medicine practitioners prescribe Rifamycin SV-MXX for self-treatment of travellers' diarrhoea? Journal of travel medicine, 2019, 05-10, Volume: 26, Issue:3 Topics: Bacteria; Ciprofloxacin; Diarrhea; Humans; Rifamycins; Travel; Travel Medicine	2019
Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers' diarrhoea: reply. Journal of travel medicine, 2019, 05-10, Volume: 26, Issue:3 Topics: Bacteria; Ciprofloxacin; Diarrhea; Humans; Rifamycins; Travel	2019